theMednetRegister

Primary Care

General Rheumatology   

Questions discussed in this category

Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
6 Answers available
How do you counsel and manage joint pain after isotretinoin treatment?
Have you found dose adjustments to be effective?
1 Answer available
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
1 Answer available
How do you treat nocturnal leg cramps?
Have you tried Vitamin K2? In light of a recent publication: Tan et al., PMID 39466236
2 Answers available
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
X-rays without inflammatory changes. RF >120, CCP >250.This question is part of a collaboration with RheumMadness and is specifically in referen...
5 Answers available
Would you use febuxostat for an African-American patient with gout and previous cardiovascular events (stroke, MI) who tested positive for HLA-B*5801?
1 Answer available
What is your approach to the management of Bell's palsy that has not improved after six months?
2 Answers available
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
3 Answers available
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Cost Effectiveness of HCQ Screening.
3 Answers available
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
The patient has no extraocular features of a spondyloarthropathy and is on methotrexate. No active eye disease for past 1 year.
2 Answers available
How do you approach a patient with elevated bone specific ALP (>2X the normal limit), but no other evidence of Paget's disease?
Normal Vitamin D, bone scan showed osteoarthritis.
1 Answer available
Is there any role for administering another course of recombinant zoster vaccine (Shingrix) in a previously vaccinated patient with RA, who is in clinical remission on JAK inhibitor but has had a breakthrough shingles infection?
The last SHINGRIX was about 4 years ago and both doses were given.
2 Answers available
How do you approach an asymptomatic patient with evidence of intense radiotracer activity at the left sternoclavicular joint on bone scan with a history of SAPHO syndrome on Humira?
Patient is asymptomatic and on therapy but has the finding on bone scan. Do we add therapy or change or do nothing and monitor only?
1 Answer available
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Do you generally feel they work well? Have patients tried using this a few days before an activity, such as skiing? Especially for otherwise healthy, ...
1 Answer available
How do you approach managing nausea and GI side effects when initiating methotrexate?
5 Answers available
Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?
Is there any data to suggest one time-frame is better than the other? The CDC states give "2024–2025 Dose 2 (Moderna, Novavax or Pfizer-BioNTec...
1 Answer available
What are your practice recommendations regarding live vaccinations in infants/children of women who are currently on DMARDs and are breastfeeding?
Does the recommendation change based on the DMARD?
1 Answer available
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
No active joint disease, patient on Hydroxychloroquine and Cimzia. Normal ESR/CRP.
1 Answer available
Do you recommend genetic screening for FMF in asymptomatic first-degree relatives with a strong family history (multiple family members, severe/refractory disease)?
1 Answer available
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
SLE manifestations include arthralgias and cytopenias which are stable. Previously did well on methotrexate, but developed GI side effects. HCQ is on ...
3 Answers available
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
2 Answers available
How long do you maintain patients with anti-synthetase syndrome on Rituximab?
The patient was treated with two doses of Rituximab and on MMF. Now with stable lung function and normalized CK.
2 Answers available
What are some of the biggest challenges you run into when patients transition from pediatric to adult care?
1 Answer available
Do you recommend adjusted adult cancer screening for patients who have been on long term biologics and/or tsDMARDs since childhood?
1 Answer available
What are some strategies to help teach patients transitioning from pediatric to adult care to become more independent with respect to their care and less dependent on their caregivers?
1 Answer available
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
1 Answer available
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
1 Answer available
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
Which csDMARD do you taper in order, and is there a tapering strategy (duration/dose)?
2 Answers available
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Given the drug-drug interaction, do you monitor more closely for methotrexate toxicity, counsel on symptoms of methotrexate toxicity, or avoid the com...
2 Answers available
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
1 Answer available
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
2 Answers available
Do you combine methotrexate and leflunomide for the treatment of RA?
3 Answers available
Is there a role for the use of transient elastography (FibroScan) to monitor liver fibrosis in patients on long term methotrexate?
3 Answers available
What is the typical timeline for remission of autoimmune hypoglycemia?
1 Answer available
Do you avoid hyaluronic acid injections in patients with chondrocalcinosis on imaging?
2 Answers available
What is your approach to work up for patients referred for early onset osteoarthritis?
1 Answer available
Do you prefer celecoxib over a nonselective NSAID in patients with chronic kidney disease?
4 Answers available
What is your approach to counseling patients regarding re-initiation of anti-TNF therapy after completion of treatment for non-disseminated pulmonary histoplasmosis?
Would it be safe to resume and if so, when?
2 Answers available
For how long do you recommend treatment for latent tuberculosis prior to initiation of anti-TNF therapy?
6 Answers available
How do you monitor patients with incidentally found high titer anti-smooth muscle antibodies without stigmata of liver disease?
3 Answers available
Do you restrict topical diclofenac use in your patients with chronic kidney disease?
3 Answers available
What do you recommend to patients when they are having an acute flare of fibromyalgia symptoms?
1 Answer available
What is your approach to monitoring for hepatic fibrosis in chronic methotrexate use?
Do you frequently order liver biopsies for these patients?This question is part of a collaboration with RheumMadness and is specifically in reference ...
2 Answers available
Do you recommend Vitamin D and omega 3 fatty acid supplementation for prevention of autoimmune disease?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Prevention of Autoimmune Disease: Vitamin D and O...
2 Answers available
How do you counsel patients on the use of topical nitroglycerin for Raynaud's?
What formulation of topical nitroglycerin do you use?
1 Answer available
How do you approach ongoing screening for TB in patients with a history of treated latent TB, but who have ongoing use of DMARDs and/or biologics given Quantiferon testing and PPD can remain positive?
How do you approach ongoing screening for TB in patients with history of treated latent TB, but have ongoing use of DMARDs and/or biologics given quan...
1 Answer available
Do you avoid the use of hydroxychloroquine in patients with psoriasis and/or psoriatic arthritis?
1 Answer available
Do you have concerns with the use of oral contraceptives in patients on JAK inhibitors given the black box warning for thromboembolic events?
How has this impacted your counseling and management?
2 Answers available
Do you counsel your patients on the potential decreased effectiveness of oral contraceptives while on Sarilumab?
If so, do you routinely recommend use of an additional form of contraception?
1 Answer available
How do you approach GI prophylaxis (e.g., PPIs, H2 blockers) in patients on long-term NSAIDs?
1 Answer available
At what point do you consider a patient to have relapsing PMR?
How much cumulative prednisone exposure do you tolerate and how many attempts at tapering will you pursue before considering addition of a steroid spa...
4 Answers available
How do you approach follow up of young patients with isolated +ANA, but no current clinical signs or symptoms of SLE?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Antibodies Before SLE.
6 Answers available
Do you consider anti-viral prophylaxis in patients taking JAK inhibitors who have recurrent uncomplicated Zoster infection, but would prefer not changing therapy?
2 Answers available
At what point would you consider anticoagulation in a pregnant patient with lupus nephritis and non-nephrotic range proteinuria?
3 Answers available
How will you approach tapering sarilumab in patients with PMR in remission?
After what interval of sustained remission will you attempt to taper, and will you do so by first widening the dosing interval?
2 Answers available
How will you adjust your approach to steroid taper in patients with PMR also on sarilumab?
2 Answers available
What baseline and ongoing testing do you recommend for patients with PMR who are going to be on a prolonged steroid taper?
Do you universally perform baseline DEXA and Hgb A1C? How often are you obtaining routine labs?
2 Answers available
How do you approach the timing of Rituximab during pregnancy in a patient with life or organ threatening autoimmune disease?
3 Answers available
Do you stop TNF inhibitors during the third trimester of pregnancy?
2 Answers available
What is your approach to patients with severe sicca symptoms and history of B Cell lymphoma?
Patient has received treatment with Rituximab and is taking hydroxychloroquine.
1 Answer available
What is your approach to tapering chronic steroids in patients who are at high risk of HPA suppression?
For example, patients who have been maintained on 5mg of prednisone for years without previous tapering attempts and the rheumatic disease is not acti...
1 Answer available
How do you approach pre-conception counseling in males who are on medications for which there is limited or no data such as Jak inhibitors, apremilast, or belimumab?
2 Answers available
Would you consider a biologic or JAK inhibitor to manage active PsA in a patient on chronic antibiotic therapy if they had previously failed all conventional DMARDs (including apremilast)?
 Patient is on antibiotics for chronic spinal hardware infection.
1 Answer available
Would you have a patient temporarily discontinue methotrexate while receiving a FAST or FAST FORWARD regimen for breast irradiation?
The patient is on a dose of 22 mg of methotrexate weekly for severe rheumatoid arthritis. If you would discontinue the methotrexate, how long would y...
1 Answer available
How would you manage tubulointerstitial nephritis and renal tubular acidosis (RTA) in a patient with Sjogren's who is pregnant?
2 Answers available
What is the optimal timing for Zoster vaccine administration for a patient who recently recovered from herpes zoster infection and is now planning to start B-cell depletion therapy?
1 Answer available
How do you counsel patients regarding alcohol intake when prescribing DMARDs other than methotrexate?
Such as Leflunomide, Sulfasalazine, Mycophenolate or Azathioprine, since all of these medications have potential to cause liver enzyme elevation and i...
1 Answer available
How do you approach management of patients with active RA and recurrent non-severe C.diff?
(Patient with active RA despite hydroxychloroquine)
1 Answer available
How do you manage injection site reactions in patients on subcutaneous biologics such as TNF inhibitors?
In what cases do you discontinue the medication?
2 Answers available
How long do you expect gastrointestinal side effects of leflunomide to persist after stopping treatment?
2 Answers available
When tapering moderate to high doses of long term steroids do you routinely monitor for adrenal insufficiency?
Do you attempt to taper fully or maintain at a low dose?
2 Answers available
Do you combine oral and topical NSAIDs for pain relief?
2 Answers available
Do you recommend patients continue folic acid for a few weeks after methotrexate discontinuation?
1 Answer available
How do you approach the use of hydroxychloroquine in patients with a history of visual field defect from another cause such as macular degeneration or diabetic retinopathy?
3 Answers available
How do you counsel patients regarding contraception use while taking mycophenolate/mycophenolic acid?
2 Answers available
What is your approach to the use of NSAIDs in patients with a history of gastric sleeve/bypass?
1 Answer available
How do you interpret elevations in ESR and CRP in the setting of increased BMI?
4 Answers available
When do you consider discontinuing Pegloticase in a patient with tophaceous gout who has had excellent response to therapy?
1 Answer available
What is your approach to patients with PMR on steroids over a prolonged initial course who start to experience weakness concerning for steroid myopathy?
1 Answer available
Do you discontinue or adjust azathioprine when a patient develops elevated MCV after starting it?
When it seems fairly certain that this is a drug effect is it something that can just be monitored or requires a change in approach?
2 Answers available
How do you approach treatment of RA with methotrexate in a patient with treated Hepatitis C and normal liver function?
1 Answer available
How do you treat celiac disease associated inflammatory arthritis refractory to gluten free diet?
1 Answer available
Are there any concerns utilizing apremilast for psoriatic arthritis in patients who are also taking roflumilast for COPD?
1 Answer available
How do you approach the continued use of TNF inhibitors in a patient with inflammatory arthritis who develops a positive dsDNA without clinical evidence of drug-induced lupus?
2 Answers available
How do you approach Covid vaccine counseling in patients with rheumatic disease and history of pericarditis/serositis?
1 Answer available
What is your approach to using apremilast for psoriatic arthritis in patients with history of depression?
1 Answer available
How do you assess potential fetal harm in patients who have unplanned pregnancy while taking teratogenic medications?
1 Answer available
How do you manage nausea in the setting of hydroxychloroquine use?
1 Answer available
In patients who develop a VTE, what conditions do you consider as persistent, provoking risk factors, and at what point are they controlled enough to stop anticoagulation?
I.e., what constitutes well-controlled cancer, IBD, nephrotic syndrome, etc. What other diseases do you put in this category (obesity, autoimmune dise...
1 Answer available
Do you refer all patients with a Beighton score over 5 to genetics for further assessment?
2 Answers available
Would you favor stopping hydralazine in a patient requiring it for refractory hypertension if they also have a high titer ANA in the absence of any SLE symptoms?
2 Answers available
When do you consider vascular imaging in patients with Raynaud's and what type of imaging modalities do you utilize?
1 Answer available
How do you approach CV risk assessment in RA patients when RA itself is associated with some degree of increased CV risk at baseline?
Recent articles regarding the use of JAK-Inhibition in RA have suggested to avoid in patients with increased CV risk.  However, RA itself is cons...
2 Answers available
Do you treat fibromyalgia in your practice or do you refer back to PCP after ruling out autoimmune inflammatory pathology?
3 Answers available
Is there a role for regular hepatitis and TB screening in patients on chronic immunosuppressive therapy in the absence of new risk factors or exposures?
1 Answer available
Are there any known contraindications for IL-23 use in patients with psoriatic arthritis and CKD or ESRD?
1 Answer available
Do you hold tocilizumab for patients who are diagnosed with Covid and are with mild to moderate symptoms or non-hospitalized?
1 Answer available
Is there a role for prednisolone over prednisone in rheumatic patients with hepatic impairment?
1 Answer available
Given the "LDL Paradox", in which RA patients with the highest levels of inflammation can have ultra-low levels of LDL (<70), how do you approach initiation of statin therapy in these patients?
Dr. Charles-Schoeman presented data at ACR 21 showing that, paradoxically, there is a U-shaped relationship between inflammation and LDL levels in pat...
1 Answer available
What is your management approach for patients with Adult Onset Still's who are planning pregnancy?
1 Answer available
How are you timing the third dose of the COVID-19 mRNA vaccine in patients on rituximab?
1 Answer available
How do you approach folate supplementation for methotrexate-related side effects?
3 Answers available
What is your approach to monitoring lipids in patients with rheumatic diseases such as RA and SLE and do you have a lower threshold to start lipid lowering agents compared to the general population?
2 Answers available
How would you counsel a patient who is interested in using supplements (such as fish oil or turmeric) as an adjunct to treatment of inflammatory arthritis?
3 Answers available
Would you consider using a TNFi in a patient with a family history of demyelinating disease, in the absence of a personal history?
2 Answers available
How do you approach management of patients with inflammatory arthritis who are asymptomatic but develop radiographic progression?
1 Answer available
What is your threshold for number of alcoholic drinks per week before reconsidering prescribing methotrexate/leflunomide?
1 Answer available
What is your approach to managing abnormal lipids in a patient on tocilizumab?
1 Answer available
How do you approach the evaluation of patients referred for chronic lyme disease and counsel patients regarding this entity?
1 Answer available
Do you switch to certolizumab in RA patients who are doing well on other TNFis and planning to become pregnant?
1 Answer available
Are you recommending the mRNA COVID-19 vaccines to your patients with immune mediated inflammatory diseases?
5 Answers available
Do you recommend shingles vaccine to all immunosuppressed patients under the age of 50 y.o.?
1 Answer available
How do you approach patients with overlapping features of PMR and seronegative RA?
1 Answer available
Do you follow patients with elevated ESR/CRP if their work-up for rheumatologic etiology is unrevealing and no other cause is identified?
2 Answers available
Is there a role for tocilizumab in treatment of polymyalgia rheumatica in patients who do not have features of giant cell arteritis or rheumatoid arthritis?
1 Answer available


Papers discussed in this category

,
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Southern medical journal, 2016-11
Effects of Statin Therapy in Patients with Systemic Lupus Erythematosus.
Annals of the rheumatic diseases, 2011-05
Lupus Atherosclerosis Prevention Study (LAPS).
Atherosclerosis, 2015 Aug 28
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
Clin Infect Dis,
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.
Cochrane Database Syst Rev, 2013 May 31
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ann Rheum Dis, 2017 Mar 23
Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
Clin Pharmacokinet,
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Gut,
Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
Arthritis and rheumatism, 2001-12
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.
J Med Food,
Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Int J Clin Pract, 2021 Apr 29
Curcumin and rheumatoid arthritis: A systematic review of literature.
Nutrients, 2020 Dec 11
Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review.
Rheumatology (Oxford),
Five successful pregnancies with antenatal anakinra exposure.
Z Rheumatol,
[IL-1-blockade with Anakinra during pregnancy : Retrospective analysis of efficacy and safety in female patients with familial Mediterranean fever].
Blood Adv,
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.
Curr Med Chem,
Targeting IL-17 and IL-23 in Immune Mediated Renal Disease.
Pathology, 2017 Mar 11
The role of interleukin-17A in the pathogenesis of kidney diseases.
Ann Rheum Dis, 2016 Oct 03
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Autoimmun Rev, 2012 Nov 30
Immunogenicity and autoimmunity during anti-TNF therapy.
Arthritis Rheum,
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Arthritis care & research, 2014-08
Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record.
Intern Med J, 2022 Mar 16
Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate.
Ann Rheum Dis, 2016 Feb 17
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
Support Care Cancer, 2019 Dec 13
Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study.
Medizinische Klinik (Munich, Germany : 1983), 2002-11-15
[Prevalence of circulating autoantibodies in healthy individuals].
Journal for scientific research. Medical sciences, 2001 Apr
Occurence of autoantibodies in healthy Omani individuals.
Current medical research and opinion, 2016-12
Corticosteroids: the knee jerk response.
Open access rheumatology : research and reviews, 2016
Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment.
Arthritis and rheumatism, 2008-09
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014-12
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
Curr Rheumatol Rep, 2022 Feb 15
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
Arthritis Care Res (Hoboken), 2017 Dec
Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.
JAMA, 1999 Dec 08
Elevated C-reactive protein levels in overweight and obese adults.
Reumatologia, 2020 Feb 28
The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis - a cross-sectional study.
The New England journal of medicine, 2003-10-16
Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
Rheumatology (Oxford, England), 2018-09-01
The SLE-key test serological signature: new insights into the course of lupus.
Lupus, 2021 Jan 05
Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort.
Arthritis Rheumatol, 2018 Jun 27
Brief Report: Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015.
J Manag Care Spec Pharm, 2022 Jul 01
Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosus.
Diagnostics (Basel), 2021 Sep 01
Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis.
Front Immunol, 2021 May 27
Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond.
Chest, 2021 Feb
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.
Expert review of clinical immunology, 2015 Dec 22
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.
The neurologist, 2017 Jul
Spectrum of Autonomic Nervous System Impairment in Sjögren Syndrome.
Arthritis Rheumatol, 2020 Apr
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Int J Environ Res Public Health, 2021 Aug 01
Relationship of Hydroxychloroquine and Ophthalmic Complications in Patients with Type 2 Diabetes in Taiwan.
Arthritis & rheumatology (Hoboken, N.J.), 2017-10
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial.
Nat Rev Nephrol, 2015 Nov 16
Renal involvement in primary Sjögren syndrome.
Clinical rheumatology, 1988 Sep
Treatment of psoriatic arthritis with sulphasalazine: a one year open study.
Journal of the American Academy of Dermatology, 1987 Apr
Gold therapy and its indications in dermatology. A review.
Journal of the American Academy of Dermatology, 2020 May 19
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.
Annals of the rheumatic diseases, 2018-09
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.
Arthritis & rheumatology (Hoboken, N.J.), 2019-02
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.
RMD open, 2020 Feb
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
The New England journal of medicine, 2014 Jun 05
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
Trials, 2022 Sep 05
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Arthritis Care Res (Hoboken), 2016 Jan
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Alimentary pharmacology & therapeutics, 2022 May 20
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
BMC nephrology, 2019 Oct 31
Clinical practice guideline on pregnancy and renal disease.
Blood, 2011-02-03
Pregnancy outcomes after maternal exposure to rituximab.
Arthritis Care Res (Hoboken), 2020 Apr
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
J Am Dent Assoc, 2016 Jan 05
Clinical practice guidelines for oral management of Sjögren disease: Dental caries prevention.
The ocular surface, 2015 Jan 15
Clinical guidelines for management of dry eye associated with Sjögren disease.
The New England journal of medicine, 2023 Oct 05
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Ann Rheum Dis, 2015 Oct
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
JAMA, 2022 Sep 20
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Arthritis care & research, 2023 Oct 26
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
Rheumatology advances in practice, 2021 Nov 27
Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study.
International journal of clinical pharmacology and therapeutics, 2014 Jan
Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis.
Science (New York, N.Y.), 1982-04-23
Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid.
Arthritis care & research, 2017-03
Influence of Alcohol Consumption on the Risk of Systemic Lupus Erythematosus Among Women in the Nurses' Health Study Cohorts.
Arthritis & rheumatology (Hoboken, N.J.), 2017-11
Association of Trauma and Posttraumatic Stress Disorder With Incident Systemic Lupus Erythematosus in a Longitudinal Cohort of Women.
Lupus, 2018-08
Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus.
Cell host & microbe, 2019-01-09
A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity.
Lupus, 2018 Oct 11
Pesticide exposure and risk of systemic lupus erythematosus in an urban population of predominantly African-American women.
Arthritis care & research, 2022 Oct 11
Association of Healthy Lifestyle Behaviors and the Risk of Developing Rheumatoid Arthritis Among Women.
BMJ (Clinical research ed.), 2022 Jan 26
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
Clinical and experimental immunology, 2003 Mar
Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice.
Environmental health perspectives, 2005 Dec
Phthalate linked to lupus in mice.
Lupus, 2001
Diet and systemic lupus erythematosus: from mouse and monkey to woman?
Auto- immunity highlights, 2012 Jan 13
Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015-08-01
Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases.
BMC public health, 2008 Jan 21
The SMILE study: a study of medical information and lifestyles in Eindhoven, the rationale and contents of a large prospective dynamic cohort study.
Annals of the rheumatic diseases, 2001 May
Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystal.
The Journal of rheumatology, 1997 May
Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis.
British journal of rheumatology, 1995 May
Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.
Lancet (London, England), 2025 Jan 25
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.
Lupus, 2014 Jul 30
Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.
MMWR. Morbidity and mortality weekly report, 2024 Sep 12
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
Diabetes research and clinical practice, 1994 Jan
Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan.
Clinical endocrinology, 2020 Feb 26
Management of Insulin Autoimmune Hypoglycaemia: Single-centre experience from Western India with systematic review of world literature.
Journal of the Endocrine Society, 2022 Dec 02
Perioperative Evaluation and Management of Patients on Glucocorticoids.
Diagnostics (Basel, Switzerland), 2021 Apr 20
Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.
Autoimmunity reviews, 2009-02
The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus.
Arthritis and rheumatism, 2013-07
Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio.
Arthritis care & research, 2016 Jan
Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lupus, 2014 Feb 06
Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity.
Annals of the rheumatic diseases, 2023 Oct 12
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Arthritis care & research, 2023 Nov 28
Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares.
Journal of the American Academy of Dermatology, 2015 Jan 30
Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature.
Journal of the European Academy of Dermatology and Venereology : JEADV, 2016 Dec 20
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
N Engl J Med,
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Autoimmunity reviews, 2023 Dec 20
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Clinical and experimental immunology, 2015 Apr
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study.
Ann Rheum Dis, 2014 Feb 13
The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.
Arthritis & rheumatology (Hoboken, N.J.), 2021 Apr 26
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.
Ophthalmology, 2016-06
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
The New England journal of medicine, 2018-03-29
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
Lancet, 2020 Nov 09
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.

Related Topics in Primary Care

Copyright © 2025 theMednet
All Rights Reserved.